Cancer-associated fibroblasts in papillary thyroid carcinoma

[1]  W. Chung,et al.  Predictive Factors Indicative of Hemithyroidectomy and Close Follow-Up versus Bilateral Total Thyroidectomy for Aggressive Variants of Papillary Thyroid Cancer , 2022, Cancers.

[2]  K. Smetana,et al.  Cancer-Associated Fibroblasts Influence the Biological Properties of Malignant Tumours via Paracrine Secretion and Exosome Production , 2022, International journal of molecular sciences.

[3]  D. Pironi,et al.  Papillary Thyroid Cancer Prognosis: An Evolving Field , 2021, Cancers.

[4]  A. Afshar-Oromieh,et al.  New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress , 2021, Pharmaceuticals.

[5]  H. Kwon,et al.  Association of Multifocality With Prognosis of Papillary Thyroid Carcinoma: A Systematic Review and Meta-analysis. , 2021, JAMA otolaryngology-- head & neck surgery.

[6]  Jiaxin Liu,et al.  Metastasis-associated fibroblasts: an emerging target for metastatic cancer , 2021, Biomarker research.

[7]  Hongmei Zhou,et al.  Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer , 2021, Signal Transduction and Targeted Therapy.

[8]  Yulei N. Wang,et al.  Cancer‐associated fibroblasts: Key players in shaping the tumor immune microenvironment , 2021, Immunological reviews.

[9]  P. Paoli,et al.  Activated fibroblasts enhance cancer cell migration by microvesicles-mediated transfer of Galectin-1 , 2021, Journal of Cell Communication and Signaling.

[10]  Jing Wang,et al.  Contextual cues from cancer cells govern cancer-associated fibroblast heterogeneity , 2021, Cell reports.

[11]  M. Chabowski,et al.  Interplay of stromal tumor-infiltrating lymphocytes, normal colonic mucosa, cancer-associated fibroblasts, clinicopathological data and the immunoregulatory molecules of patients diagnosed with colorectal cancer , 2021, Cancer Immunology, Immunotherapy.

[12]  M. Papotti,et al.  Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: From Echography to Genetic Profile. , 2020, The Tohoku journal of experimental medicine.

[13]  F. Rashid,et al.  Prevalence of BRAFV600E mutation in Asian series of papillary thyroid carcinoma-a contemporary systematic review. , 2020, Gland surgery.

[14]  Xiuxiu Xu,et al.  Immunohistochemical detection of cancer-associated fibroblasts in gastrointestinal cancer as a potential prognostic biomarker of survival: meta-analysis , 2020, Translational cancer research.

[15]  F. Basolo,et al.  Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up , 2020, Endocrine.

[16]  J. Shah,et al.  Should multifocality be an indication for completion thyroidectomy in papillary thyroid carcinoma? , 2020, Surgery.

[17]  Masahide Takahashi,et al.  Cancer-associated fibroblasts in gastrointestinal cancer , 2019, Nature Reviews Gastroenterology & Hepatology.

[18]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[19]  K. Jung,et al.  Clinicopathological significance of cancer-associated fibroblasts in papillary thyroid carcinoma: a predictive marker of cervical lymph node metastasis , 2018, European Archives of Oto-Rhino-Laryngology.

[20]  Nancy D Perrier,et al.  Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual , 2018, CA: a cancer journal for clinicians.

[21]  Qinghua Zhou,et al.  Cancer-associated fibroblasts enhance metastatic potential of lung cancer cells through IL-6/STAT3 signaling pathway , 2017, Oncotarget.

[22]  L. J. K. Wee,et al.  Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors , 2017, Nature Genetics.

[23]  R. Kalluri.  The biology and function of fibroblasts in cancer , 2016, Nature Reviews Cancer.

[24]  Xiulan Zhao,et al.  Reprogramming carcinoma associated fibroblasts by AC1MMYR2 impedes tumor metastasis and improves chemotherapy efficacy. , 2016, Cancer letters.

[25]  S. Mandel,et al.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[26]  W. Jung,et al.  Expression of cancer-associated fibroblast-related proteins in thyroid papillary carcinoma , 2016, Tumor Biology.

[27]  G. Charras,et al.  Cdc42EP3/BORG2 and Septin Network Enables Mechano-transduction and the Emergence of Cancer-Associated Fibroblasts , 2015, Cell reports.

[28]  Xing-hua Song,et al.  Immunohistochemical evaluation of midkine and nuclear factor-kappa B as diagnostic biomarkers for papillary thyroid cancer and synchronous metastasis. , 2014, Life sciences.

[29]  J. Bouchal,et al.  The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance , 2014, Cancer Cell International.

[30]  David F. Schneider,et al.  Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases. , 2013, Thyroid : official journal of the American Thyroid Association.

[31]  Jie Zhang,et al.  Notch and TGF-β/Smad3 pathways are involved in the interaction between cancer cells and cancer-associated fibroblasts in papillary thyroid carcinoma , 2013, Tumor Biology.

[32]  H. Yamashita,et al.  Indications for bilateral modified radical neck dissection in patients with papillary carcinoma of the thyroid. , 2000, Archives of surgery.

[33]  Z. Baloch,et al.  Encapsulated Follicular Variant of Papillary Thyroid Carcinoma with Bone Metastases , 2000, Modern Pathology.